3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Brain Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Carcinoma, Non-Small-Cell Lung
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Neoplasms
3
Meningioma
3
Glioma
3
Esophageal Neoplasms
3
Pituitary Neoplasms
2
Osteosarcoma
2
Nerve Sheath Neoplasms
2
Glioblastoma
2
Craniopharyngioma
2
Chordoma
2
Chondrosarcoma
2
Breast Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Interventions
Bevacizumab
67
atezolizumab
53
durvalumab
43
lenvatinib
42
Nivolumab
38
pembrolizumab
35
tremelimumab
29
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Proton Therapy
×
1 year
×
Clear all
No trials found.